OTC Monograph Application Reviews Get Deadlines, Not GRASE Flexibility

Changes to FDA's interpretation of the GRASE standard it uses to evaluate ingredient proposals would go further to opening the US monograph process to innovation and progress than setting deadlines for the reviews, industry stakeholders say.